Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06365840
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-15
First Post:
2024-04-10
Brief Title:
A Study of Phase2 IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor
Sponsor:
ImmuneOncia Therapeutics Inc
Organization:
ImmuneOncia Therapeutics Inc
Organization Data
Organization:
ImmuneOncia Therapeutics Inc
Class:
INDUSTRY
Study ID:
IMC-001-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ImmuneOncia Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None